ASO Author Reflections: Extent of Resection Not Associated with Disease-Specific Survival in Patients with Localized Mucinous Adenocarcinoma of the Appendix
Ann Surg Oncol. 2024 Apr 15. doi: 10.1245/s10434-024-15289-7. Online ahead of print.NO ABSTRACTPMID:38622457 | DOI:10.1245/s10434-024-15289-7 (Source: Ann Oncol)
Source: Ann Oncol - April 15, 2024 Category: Cancer & Oncology Authors: Vasileios Tsagkalidis Brett L Ecker Source Type: research
The Influence of Surgical Complexity and Center Experience on Postoperative Morbidity After Minimally Invasive Surgery in Gynecologic Oncology: Lessons Learned from the ROBOGYN-1004 Trial
CONCLUSION: The findings suggest that the center's experience may have an impact on the risk of morbidity for patients undergoing complex robot-assisted surgical procedures.PMID:38616209 | DOI:10.1245/s10434-024-15265-1 (Source: Ann Oncol)
Source: Ann Oncol - April 14, 2024 Category: Cancer & Oncology Authors: Eric Lambaudie Emilie Bogart Marie-C écile Le Deley Houssein El Hajj Tristan Gauthier Thomas Hebert Pierre Collinet Jean Marc Classe Fabrice Lecuru Stephanie Motton Vanessa Conri Catherine Ferrer Frederic Marchal Gwenael Ferron Alicia Probst Camille Jauf Source Type: research
The Influence of Surgical Complexity and Center Experience on Postoperative Morbidity After Minimally Invasive Surgery in Gynecologic Oncology: Lessons Learned from the ROBOGYN-1004 Trial
CONCLUSION: The findings suggest that the center's experience may have an impact on the risk of morbidity for patients undergoing complex robot-assisted surgical procedures.PMID:38616209 | DOI:10.1245/s10434-024-15265-1 (Source: Ann Oncol)
Source: Ann Oncol - April 14, 2024 Category: Cancer & Oncology Authors: Eric Lambaudie Emilie Bogart Marie-C écile Le Deley Houssein El Hajj Tristan Gauthier Thomas Hebert Pierre Collinet Jean Marc Classe Fabrice Lecuru Stephanie Motton Vanessa Conri Catherine Ferrer Frederic Marchal Gwenael Ferron Alicia Probst Camille Jauf Source Type: research
Upfront neck dissection to guide single-modality therapy for early stage supraglottic squamous cell carcinoma
Oral Oncol. 2024 Apr 12;152:106803. doi: 10.1016/j.oraloncology.2024.106803. Online ahead of print.NO ABSTRACTPMID:38613849 | DOI:10.1016/j.oraloncology.2024.106803 (Source: Ann Oncol)
Source: Ann Oncol - April 13, 2024 Category: Cancer & Oncology Authors: Joshua D Smith Molly E Heft-Neal Andrew J Rosko Douglas B Chepeha Matthew E Spector Source Type: research
Corrigendum to 'Long-term outcomes to neoadjuvant pembrolizumab based on pathological response for patients with resectable stage III/IV cutaneous melanoma': [Annals of Oncology 34 (2023) 806-812]
Ann Oncol. 2024 Apr 13:S0923-7534(24)00076-0. doi: 10.1016/j.annonc.2024.03.002. Online ahead of print.NO ABSTRACTPMID:38614876 | DOI:10.1016/j.annonc.2024.03.002 (Source: Ann Oncol)
Source: Ann Oncol - April 13, 2024 Category: Cancer & Oncology Authors: C E Sharon G N Tortorello K L Ma A C Huang X Xu L R Giles S McGettigan K Kreider L M Schuchter A J Mathew R K Amaravadi P A Gimotty J T Miura G C Karakousis T C Mitchell Source Type: research
ASO Author Reflections: The Integration of Precision Anatomy Concepts into Minimally Invasive Liver Surgery-A New Way to Approach Routine Clinical Practice Complex Situations
Ann Surg Oncol. 2024 Apr 13. doi: 10.1245/s10434-024-15287-9. Online ahead of print.NO ABSTRACTPMID:38615150 | DOI:10.1245/s10434-024-15287-9 (Source: Ann Oncol)
Source: Ann Oncol - April 13, 2024 Category: Cancer & Oncology Authors: Fernando Rotellar Nuria Blanco Daniel Aliseda Pablo Mart í-Cruchaga Gabriel Zozaya Source Type: research
Paraaortic Extra-Adrenal Paraganglioma: Challenging Robotic Resection
CONCLUSIONS: Robotic-assisted resection can be safe and effective for retroperitoneal malignant paragangliomas. However, management extends beyond surgery and requires cascade genetic testing to address familial risks. Because of the high probability of cancer associated with SDHB mutation, lifelong patient surveillance is imperative.PMID:38615151 | DOI:10.1245/s10434-024-15267-z (Source: Ann Oncol)
Source: Ann Oncol - April 13, 2024 Category: Cancer & Oncology Authors: Andrei Nikiforchin Ekaterina Baron Jessica A Wernberg Rohit Sharma Source Type: research
En Bloc Resection of Sentinel Lymph Nodes with the Hysterectomy Specimen in Endometrial Cancer
CONCLUSION: This novel surgical technique emphasizes the importance of anatomical knowledge and offers inspiration for studies with potential clinical benefit that should follow.PMID:38615152 | DOI:10.1245/s10434-024-15234-8 (Source: Ann Oncol)
Source: Ann Oncol - April 13, 2024 Category: Cancer & Oncology Authors: Manolis Nikolopoulos Vasileios Mitsopoulos Anni Innamaa Jonathan Lippiatt Ioannis Biliatis Source Type: research
Upfront neck dissection to guide single-modality therapy for early stage supraglottic squamous cell carcinoma
Oral Oncol. 2024 Apr 12;152:106803. doi: 10.1016/j.oraloncology.2024.106803. Online ahead of print.NO ABSTRACTPMID:38613849 | DOI:10.1016/j.oraloncology.2024.106803 (Source: Ann Oncol)
Source: Ann Oncol - April 13, 2024 Category: Cancer & Oncology Authors: Joshua D Smith Molly E Heft-Neal Andrew J Rosko Douglas B Chepeha Matthew E Spector Source Type: research
Nivolumab with or without ipilimumab in patients with recurrent or metastatic cervical cancer (CheckMate 358): a phase 1-2, open-label, multicohort trial
This study is registered with ClinicalTrials.gov (NCT02488759) and is now completed.FINDINGS: Between October, 2015, and March, 2020, 193 patients were recruited in the recurrent or metastatic cervical cancer cohort of CheckMate 358, of whom 176 were treated. 19 patients received nivolumab monotherapy, 45 received NIVO3 plus IPI1, and 112 received NIVO1 plus IPI3 (45 in the randomised group and 67 in the expansion group). Median follow-up times were 19·9 months (IQR 8·2-44·8) with nivolumab, 12·6 months (7·8-37·1) with NIVO3 plus IPI1, and 16·7 months (7·2-27·5) with pooled NIVO1 plus IPI3. Objective response rate...
Source: Ann Oncol - April 12, 2024 Category: Cancer & Oncology Authors: Ana Oaknin Kathleen Moore Tim Meyer Jos é López-Picazo González Lot A Devriese Asim Amin Christopher D Lao Valentina Boni William H Sharfman Jong Chul Park Makoto Tahara Suzanne L Topalian Manuel Magallanes Alejandro Molina Alavez Tariq Aziz Khan Cathe Source Type: research
ASO Author Reflections: Changes in the Urinary Microbiome After Transurethral Resection of Nonmuscle-Invasive Bladder Cancer: Insights from a Prospective Observational Study
Ann Surg Oncol. 2024 Apr 11. doi: 10.1245/s10434-024-15248-2. Online ahead of print.NO ABSTRACTPMID:38602577 | DOI:10.1245/s10434-024-15248-2 (Source: Ann Oncol)
Source: Ann Oncol - April 11, 2024 Category: Cancer & Oncology Authors: Aleksander Ślusarczyk Source Type: research
Differences in Lymph Node Metastases Patterns Among Non-pancreatic Periampullary Cancers and Histologic Subtypes: An International Multicenter Retrospective Cohort Study and Systematic Review
CONCLUSION: This study is the first to comprehensively demonstrate the differences and similarities in lymph node metastases spread among NPPCs, to identify the existing research gaps, and to underscore the importance of standardized lymphadenectomy and pathologic assessment for AAC, dCCA, and DAC.PMID:38602578 | DOI:10.1245/s10434-024-15213-z (Source: Ann Oncol)
Source: Ann Oncol - April 11, 2024 Category: Cancer & Oncology Authors: Bas A Uijterwijk Dani ël H Lemmers Giuseppe Kito Fusai Alessandro Zerbi Roberto Salvia Ernesto Sparrelid Steven White Bergthor Bj örnsson Vasileios K Mavroeidis Keith J Roberts Michele Mazzola Santiago S ánchez Cabús Zahir Soonawalla Dimitris Korkolis Source Type: research
ASO Author Reflections: ICC PRS Score: Clinically Useful Tool to Predict Post-recurrence Survival and Guide Management of Recurrent Intrahepatic Cholangiocarcinoma
Ann Surg Oncol. 2024 Apr 11. doi: 10.1245/s10434-024-15269-x. Online ahead of print.NO ABSTRACTPMID:38602579 | DOI:10.1245/s10434-024-15269-x (Source: Ann Oncol)
Source: Ann Oncol - April 11, 2024 Category: Cancer & Oncology Authors: Diamantis I Tsilimigras Timothy M Pawlik Source Type: research
Phase II Study of Erdafitinib in Patients With Tumors With < em > FGFR < /em > Amplifications: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K1
CONCLUSION: Erdafitinib did not meet its primary end point of efficacy as determined by ORR in treatment-refractory solid tumors harboring FGFR1-4 amplifications. Our findings support that rearrangements and gene mutations, but not amplifications, of FGFR remain the established FGFR alterations with approved indications for FGFR inhibition.PMID:38603651 | DOI:10.1200/PO.23.00406 (Source: Ann Oncol)
Source: Ann Oncol - April 11, 2024 Category: Cancer & Oncology Authors: Jun Gong Alain C Mita Zihan Wei Heather H Cheng Edith P Mitchell John J Wright S Percy Ivy Victoria Wang Robert C Gray Lisa M McShane Larry V Rubinstein David R Patton P Mickey Williams Stanley R Hamilton Ajjai S Alva James V Tricoli Barbara A Conley Carl Source Type: research
Regorafenib in Patients With Solid Tumors With < em > BRAF < /em > Alterations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
CONCLUSION: Regorafenib did not meet prespecified criteria to declare a signal of activity in patients with solid tumors with BRAF alterations.PMID:38603652 | PMC:PMC10896467 | DOI:10.1200/PO.23.00527 (Source: Ann Oncol)
Source: Ann Oncol - April 11, 2024 Category: Cancer & Oncology Authors: Vaibhav Sahai Michael Rothe Pam K Mangat Elizabeth Garrett-Mayer Vijay Suhag Elie G Dib Inderjit Mehmi Kunal C Kadakia Evan Pisick Herbert L Duvivier Phat Le Rui Li David P Michelin Ryan E Wilcox Gina N Grantham Dominique C Hinshaw Abigail Gregory Susan H Source Type: research
